Catalyst Wire Dossier Catalyst Wire Dossier

Ibuprofen 400 mg/10 mL oral suspension

ibuprofen · Aziende Chimiche Riunite Angelini Francesco S.p.A
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ibuprofen 400 mg/10 mL oral suspension, covering 2016-09-15 to 2016-09-15. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of Ibuprofen 400 mg/10 mL Oral Suspension vs. MOMENTACT 400 mg Film-coated Tablet [Phase 1]

See pricing